Technical Analysis for ACR - Acrux Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Strong but Oversold | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 1.67% | |
| Narrow Range Bar | Range Contraction | 1.67% | |
| Stochastic Reached Oversold | Weakness | 1.67% | |
| Strong but Oversold | Other | 1.67% | |
| Wide Bands | Range Expansion | 1.67% | |
| Oversold Stochastic | Weakness | 1.67% |
| Alert | Time |
|---|---|
| Boomer Buy Entry | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Rose Above 10 DMA | 1 day ago |
| Up 1% | 1 day ago |
| Gapped Up (Full) | 3 days ago |
Get this analysis on your stocks daily!
Acrux Limited Description
Acrux Limited is a drug development company. The Company is engaged in developing and commercializing branded and generic transdermal and topical pharmaceuticals for global markets. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The Company's products include Axiron, Ellavie, Evamist and Lenzetto. Axiron (testosterone) topical solution CIII is a testosterone topical solution approved for application via an armpit (underarm) applicator. It has developed the estradiol spray for women, used to treat moderate to severe hot flushes commonly associated with menopause. In the United States, the Company's estradiol spray is branded Evamist. The Company has licensed its estradiol product to Gedeon Richter to commercialize in various territories, including Europe and Eurasia. Gedeon Richter has branded the estradiol spray as Lenzetto.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Iron Pharmaceutical Radio Pharmaceuticals Flu Pharmaceutical Products Drug Development Organic Compounds Pau Transdermal Endocrine System Generic Pharmaceutical Product Generic Pharmaceutical Products Topical Medication
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.099 |
| 52 Week Low | 0.035 |
| Average Volume | 988,368 |
| 200-Day Moving Average | 0.050 |
| 50-Day Moving Average | 0.057 |
| 20-Day Moving Average | 0.060 |
| 10-Day Moving Average | 0.061 |
| Average True Range | 0.004 |
| RSI (14) | 53.70 |
| ADX | 39.07 |
| +DI | 43.431 |
| -DI | 21.533 |
| Chandelier Exit (Long, 3 ATRs) | 0.087 |
| Chandelier Exit (Short, 3 ATRs) | 0.059 |
| Upper Bollinger Bands | 0.074 |
| Lower Bollinger Band | 0.046 |
| Percent B (%b) | 0.53 |
| BandWidth | 46.512 |
| MACD Line | 0.001 |
| MACD Signal Line | 0.002 |
| MACD Histogram | -0.0003 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.061 | ||||
| Resistance 3 (R3) | 0.061 | 0.061 | 0.061 | ||
| Resistance 2 (R2) | 0.061 | 0.061 | 0.061 | 0.061 | |
| Resistance 1 (R1) | 0.061 | 0.061 | 0.061 | 0.061 | 0.061 |
| Pivot Point | 0.061 | 0.061 | 0.061 | 0.061 | 0.061 |
| Support 1 (S1) | 0.061 | 0.061 | 0.061 | 0.061 | 0.061 |
| Support 2 (S2) | 0.061 | 0.061 | 0.061 | 0.061 | |
| Support 3 (S3) | 0.061 | 0.061 | 0.061 | ||
| Support 4 (S4) | 0.061 |
